Ocsaar and CYP2C9 Ploymorphism, Is There a Connection Between Pharmacokinetics, Pharmacodynamics and Pharmacogenetics?

NCT00732966 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

30

Enrollment

OTHER_GOV

Sponsor class

Conditions

Hypertension

Interventions

DRUG: losartan
DRUG: valsartan

Sponsor

Assaf-Harofeh Medical Center